How to Buy Veracyte Stock
Veracyte Inc
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.
Veracyte stock last closed at $26.44, down 0.94% from the previous day, and has increased 21.34% in one year. It has overperformed other stocks in the Biotechnology industry by 0.98 percentage points. Veracyte stock is currently +34.01% from its 52-week low of $19.73, and -44.12% from its 52-week high of $47.32.
As of Jun 13, 2025, there are 78.31M VCYT shares outstanding. The market cap of VCYT is $2.07B. In the past 24 hours, 954,000 VCYT shares were traded.
How to Buy Veracyte Stock
Not sure how to invest in Veracyte stock? Here's how.
- Choose where to buy Veracyte stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Veracyte stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your payment method and add your information.
- Research Veracyte stock: The Veracyte ticker symbol is VCYT. Is Veracyte stock a good investment? Should you buy shares of VCYT? How do VCYT's underlying business fundamentals look? Do top analysts think Veracyte is a good buy? Why has VCYT's stock price moved recently? (Hint: Our stock research website can help you figure out if VCYT is a good stock to buy).
- Place your VCYT buy order: Decide if you will purchase VCYT shares at the current market price or use a limit order to purchase VCYT stock at a particular price.
- Keep an eye on your VCYT position: Create a watchlist to get the latest news on your new investment in Veracyte stock.
Step 1: Choose where to buy Veracyte stock
You will need a brokerage account in order to access the NASDAQ market and buy VCYT stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal information so you can invest in VCYT today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on the best stock trading app, you need to deposit funds:
Watch the video below if you need help transferring money into your new brokerage account.
Step 4: Research Veracyte stock
After you have figured out the best place to buy Veracyte stock, it's critical to research their stock prior to investing, so you truly wrap your head around the risk and opportunity.
Veracyte shares at a glance
Fundamentals of Veracyte
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on VCYT's stock page.
How is VCYT stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge VCYT's intrinsic value.
Using relative valuations ratios:
- VCYT could be undervalued based on its P/E ratio of 61.49x, relative to Biotechnology industry P/E ratio of -108.97x
- VCYT could be undervalued based on its P/B ratio of 1.73x, relative to Biotechnology industry P/B ratio of 4.66x
- VCYT could be overvalued based on its PEG ratio of 1.38x
You can do additional valuation research on VCYT's stock here.
VCYT Financial Overview
Signs that VCYT is financially healthy:
- There are more short-term assets than long-term liabilities on the VCYT balance sheet.
- VCYT's operating cash flow of $89.42M allows it to safely service it's debt of $50.50M.
- Total VCYT debt is lower than 5 years ago, relative to shareholder equity.
- VCYT has a low debt to equity ratio of 0.1.
- VCYT profit margin has gone up from -18.2% to 7.1% in the past year.
- VCYT earnings of $35.08M is not sufficient to cover its interest payments.
- There are more short-term assets than short-term liabilities on the VCYT balance sheet.
Do analysts think it's a good time to buy VCYT stock
Out of 5 Equities analysts who give ratings on VCYT, the consensus analyst rating on Veracyte is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Veracyte stock forecast page.
VCYT Technicals
VCYT Performance Metrics
Last year, VCYT revenue was $463.39M. In the past five year, VCYT's revenue has grown by 30.6% per year. This was slower than the Biotechnology industry average of 43.24%.
Dive into VCYT's earnings and revenue performance here.
What are VCYT insiders up to?
Over the last year, executives and large shareholders at VCYT have sold more shares than they have bought.
John Leite, Chief Commercial Officer-CLIA of VCYT, was the latest VCYT insider to sell. They sold $76,410.42 worth of VCYT shares on Jun 4, 2025.
Research more about who owns VCYT shares here.
Can I get consistent income from VCYT stock?
No, Veracyte doesn't provide an income stream by paying out dividends.
What others are saying about VCYT
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your VCYT buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Press the Open button and eToro will place the order.
If you require additional assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your VCYT position
Now that you own some shares in VCYT, you'll want to stay up-to-date on your new investment.
Put VCYT on a watchlist to get notified of important updates regarding your VCYT stock.
VCYT Feed
How to Buy Stock in Veracyte
To reiterate, here are the 6 steps you need to take to buy Veracyte stock right now:
- Choose where to buy Veracyte stock
- Create a brokerage account
- Deposit money your brokerage account
- Research Veracyte stock
- Place your VCYT buy order
- Keep an eye on your VCYT position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Veracyte, create your watchlist below.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.